Imaging Review of Paraneoplastic Neurologic Syndromes

References

1. 1.↵
   1. Kelley BP,
   2. Patel SC,
   3. Marin HL, et al

   . Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol 2017;38:1070–78 doi:10.3174/ajnr.A5086 pmid:28183838

   Abstract/FREE Full Text
2. 2.↵
   1. Leypoldt F,
   2. Wandinger KP

   . Paraneoplastic neurological syndromes. Clin Exp Immunol 2014;175:336–48 doi:10.1111/cei.12185 pmid:23937626

   CrossRefPubMed
3. 3.↵
   1. Lancaster E,
   2. Huijbers MG,
   3. Bar V, et al

   . Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303–11 doi:10.1002/ana.22297 pmid:21387375

   CrossRefPubMedWeb of Science
4. 4.↵
   1. da Rocha AJ,
   2. Nunes RH,
   3. Maia AC Jr., et al

   . Recognizing autoimmune-mediated encephalitis in the differential diagnosis of limbic disorders. AJNR Am J Neuroradiol 2015;36:2196–205 doi:10.3174/ajnr.A4408 pmid:26381566

   Abstract/FREE Full Text
5. 5.↵
   1. Fredriksen JR,
   2. Carr CM,
   3. Koeller KK, et al

   . MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy. Neuroradiology 2018;60:239–45 doi:10.1007/s00234-018-1976-6 pmid:29353399

   CrossRefPubMed
6. 6.↵
   1. Guerin J,
   2. Watson RE,
   3. Carr CM, et al

   . Autoimmune epilepsy: findings on MRI and FDG-PET. Br J Radiology 2019;92:20170869 doi:10.1259/bjr.20170869 pmid:30235015

   CrossRefPubMed
7. 7.↵
   1. Dutra LA,
   2. Abrantes F,
   3. Toso FF, et al

   . Autoimmune encephalitis: a review of diagnosis and treatment. Arq Neuropsiquiatr 2018;76:41–49 doi:10.1590/0004-282X20170176 pmid:29364393

   CrossRefPubMed
8. 8.↵
   1. Lancaster E

   . The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 2016;12:1–13 doi:10.3988/jcn.2016.12.1.1 pmid:26754777

   CrossRefPubMed
9. 9.↵
   1. Hoftberger R,
   2. Rosenfeld MR,
   3. Dalmau J

   . Update on neurological paraneoplastic syndromes. Curr Opin Oncol 2015;27:489–95 doi:10.1097/CCO.0000000000000222 pmid:26335665

   CrossRefPubMed
10. 10.↵
    1. Jarius S,
    2. Wildemann B

    . “Medusa head ataxia”: the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook. J Neuroinflammation 2015;12:168 doi:10.1186/s12974-015-0358-9 pmid:26377319

    CrossRefPubMed
11. 11.↵
    1. Mahta A,
    2. Vijayvergia N,
    3. Bhavsar TM, et al

    . Diagnostic approach to a patient with paraneoplastic neurological syndrome. World J Oncol 2012;3:243–46 doi:10.4021/wjon571w pmid:29147315

    CrossRefPubMed
12. 12.↵
    1. Campos LG,
    2. Trindade RA,
    3. Faistauer A, et al

    . Rhombencephalitis: pictorial essay. Radiology Bras 2016;49:329–36 doi:10.1590/0100-3984.2015.0189 pmid:27818548

    CrossRefPubMed
13. 13.↵
    1. Mandel-Brehm C,
    2. Dubey D,
    3. Kryzer TJ, et al

    . Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N Engl J Med 2019;381:47–54 doi:10.1056/NEJMoa1816721 pmid:31269365

    CrossRefPubMed
14. 14.↵
    1. Boch M,
    2. Rinke A,
    3. Rexin P, et al

    . Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasm. BMC Cancer 2014;14:691 doi:10.1186/1471-2407-14-691 pmid:25244967

    CrossRefPubMed
15. 15.↵
    1. Jubelt B,
    2. Mihai C,
    3. Li TM, et al

    . Rhombencephalitis/brainstem encephalitis. Curr Neurol Neurosci Rep 2011;11:543–52 doi:10.1007/s11910-011-0228-5 pmid:21956758

    CrossRefPubMed
16. 16.↵
    1. Cheung SSL,
    2. Lau GKK,
    3. Chan KH, et al

    . Optic neuritis as the initial clinical presentation of limbic encephalitis: a case report. J Med Case Rep 2018;12:357 doi:10.1186/s13256-018-1893-7 pmid:30509326

    CrossRefPubMed
17. 17.↵
    1. Renna R,
    2. Plantone D,
    3. Batocchi AP

    . Teaching NeuroImages: a case of hearing loss in a paraneoplastic syndrome associated with anti-Hu antibody. Neurology 2012;79:e134 doi:10.1212/WNL.0b013e31826e262b pmid:23045521

    CrossRefPubMed
18. 18.↵
    1. Kaido M,
    2. Yuasa Y,
    3. Yamamoto T, et al

    . A case of possible paraneoplastic neurological syndrome presenting as multiple cranial nerve palsies associated with gallbladder cancer. Rinsho Shinkeigaku 2016;56:617–21 doi:10.5692/clinicalneurol.cn-000906 pmid:27498818

    CrossRefPubMed
19. 19.↵
    1. Nanda SK,
    2. Jayalakshmi S,
    3. Ruikar D, et al

    . Twelfth cranial nerve involvement in Guillain Barre syndrome. J Neurosci Rural Pract 2013;4:338–40 doi:10.4103/0976-3147.118804 pmid:24250180

    CrossRefPubMed
20. 20.↵
    1. Inoue H,
    2. Tsuboi Y,
    3. Tsugawa J, et al

    . Hypertrophic cranial nerve roots in CIDP. Neurology 2004;63:1481 doi:10.1212/01.wnl.0000137033.77605.b2 pmid:15505169

    FREE Full Text
21. 21.↵
    1. Flanagan EP,
    2. McKeon A,
    3. Lennon VA, et al

    . Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 2011;76:2089–95 doi:10.1212/WNL.0b013e31821f468f pmid:21670438

    Abstract/FREE Full Text
22. 22.↵
    1. Pittock SJ,
    2. Lennon VA,
    3. de Seze J, et al

    . Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol 2008;65:78–83 doi:10.1001/archneurol.2007.17 pmid:18195142

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Keegan BM,
    2. Flanagan EP

    . In reply—Sensitivity of [18F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy. Mayo Clin Proc 2014;89:859 doi:10.1016/j.mayocp.2014.03.009 pmid:24943702

    CrossRefPubMed
24. 24.↵
    1. Graus F,
    2. Santamaría J,
    3. Obach J, et al

    . Sensory neuropathy as remote effect of cancer. Neurology 1987;37:1266–67 doi:10.1212/wnl.37.7.1266-b pmid:3037442

    FREE Full Text
25. 25.↵
    1. Al IO,
    2. Koc B,
    3. Bayram C, et al

    . Variant Guillain-Barré syndrome in a patient with Hodgkin lymphoma: AMSAN. Turk Pediatri Ars 2019;53:263–66 doi:10.5152/TurkPediatriArs.2018.4763

    CrossRef
26. 26.
    1. Choi JK,
    2. Kim WJ,
    3. Jeon JY

    . Paraneoplastic sensorimotor polyneuropathy in prostatic adenocarcinoma: a case report. Medicine (Baltimore) 2018;97:e0030 doi:10.1097/MD.0000000000010030 pmid:29642138

    CrossRefPubMed
27. 27.↵
    1. Nomiyama K,
    2. Uchino A,
    3. Yakushiji Y, et al

    . Diffuse cranial nerve and cauda equina lesions associated with breast cancer. Clin Imaging 2007;31:202–05 doi:10.1016/j.clinimag.2007.01.006 pmid:17449382

    CrossRefPubMed
28. 28.↵
    1. Veilleux M,
    2. Bernier JP,
    3. Lamarche JB

    . Paraneoplastic encephalomyelitis and subacute dysautonomia due to an occult atypical carcinoid tumour of the lung. Can J Neurol Sci 1990;17:324–28 doi:10.1017/s0317167100030675 pmid:2207890

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Kumar N,
    2. Dyck PJ

    . Hypertrophy of the nerve roots of the cauda equina as a paraneoplastic manifestation of lymphoma. Arch Neurol 2005;62:1776–77 doi:10.1001/archneur.62.11.1776 pmid:16286555

    CrossRefPubMed
30. 30.
    1. Flanagan EP,
    2. Sandroni P,
    3. Pittock SJ, et al

    . Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerve 2012;46:823–27 doi:10.1002/mus.23464 pmid:23055320

    CrossRefPubMed
31. 31.
    1. Shibata M,
    2. Uchida M,
    3. Tsukagoshi S, et al

    . Anti-Hu antibody-associated paraneoplastic neurological syndrome showing peripheral neuropathy and atypical multifocal brain lesions. Intern Med 2015;54:3057–60 doi:10.2169/internalmedicine.54.4867 pmid:26631892

    CrossRefPubMed
32. 32.↵
    1. Madhavan AA,
    2. Guerin JB,
    3. Eckel LJ, et al

    . Dorsal cauda equina nerve root enhancement on magnetic resonance imaging due to ANNA-1-associated paraneoplastic polyneuropathy. Neuroradiol J 2020 Apr 15 [Epub ahead of print] doi:10.1177/1971400920919689 pmid:32290766

    CrossRefPubMed
33. 33.↵
    1. Paranavitane S,
    2. Gooneratne L,
    3. Chang T

    . Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report. J Med Case Rep 2019;13:384 doi:10.1186/s13256-019-2309-z pmid:31878962

    CrossRefPubMed
34. 34.↵
    1. Diehn FE,
    2. Hunt CH,
    3. Lehman VT, et al

    . Vertebral body infarct and ventral cauda equina enhancement: two confirmatory findings of acute spinal cord infarct. J Neuroimaging 2015;25:133–35 doi:10.1111/jon.12058 pmid:24118402

    CrossRefPubMed